NCT01766414View on ClinicalTrials.gov

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II

PHASE3CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions

Innate Immune ResponseEndotoxemiaInflammationSepsis

Interventions

DRUG

C1-esterase inhibitor

intravenously

DRUG

Endotoxin

intravenously

Trial Locations (1)

Unknown

Radboud University, Nijmegen

Sponsors

Collaborators (1)

Prothya Biosolutions

All Listed Sponsors

collaborator

UMC Utrecht

OTHER

collaborator

Prothya Biosolutions

INDUSTRY

lead

Radboud University Medical Center

OTHER